Works by Gatt, Moshe E

Results: 48
    1
    2
    3

    Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?

    Published in:
    Cancers, 2023, v. 15, n. 13, p. 3471, doi. 10.3390/cancers15133471
    By:
    • Vainstein, Vladimir;
    • Avni, Batia;
    • Grisariu, Sigal;
    • Kfir-Erenfeld, Shlomit;
    • Asherie, Nathalie;
    • Nachmias, Boaz;
    • Auman, Shlomtzion;
    • Saban, Revital;
    • Zimran, Eran;
    • Assayag, Miri;
    • Filanovsky, Kalman;
    • Horowitz, Netanel A.;
    • Lebel, Eyal;
    • Shaulov, Adir;
    • Gur, Michal;
    • Rosenbluh, Chaggai;
    • Krichevsky, Svetlana;
    • Stepensky, Polina;
    • Gatt, Moshe E.
    Publication type:
    Article
    4
    5
    6
    7

    Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study Group.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 14, p. 3448, doi. 10.1080/10428194.2022.2118535
    By:
    • Ganzel, Chezi;
    • Trestman, Svetlana;
    • Levi, Shai;
    • Gatt, Moshe E.;
    • Lavi, Noa;
    • Vaxman, Iuliana;
    • Rouvio, Ory;
    • Magen, Hila;
    • Lebel, Eyal;
    • Horowitz, Netanel A.;
    • Leiba, Merav;
    • Tadmor, Tamar;
    • Herzog Tzarfati, Katrin;
    • Surio, Celia;
    • Yeganeh, Shay;
    • Dally, Nagib;
    • Avivi, Irit;
    • Cohen, Yael C.
    Publication type:
    Article
    8
    9
    10
    11
    12

    An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma.

    Published in:
    Cell Death & Disease, 2022, v. 13, n. 11, p. 1, doi. 10.1038/s41419-022-05421-4
    By:
    • Darawshi, Odai;
    • Muz, Barbara;
    • Naamat, Shiri Gershon;
    • Praveen, Bellam;
    • Mahameed, Mohamed;
    • Goldberg, Karin;
    • Dipta, Priya;
    • Shmuel, Miriam;
    • Forno, Francesca;
    • Boukeileh, Shatha;
    • Pahima, Hadas;
    • Hermann, Julia;
    • Raab, Marc S.;
    • Poos, Alexandra M.;
    • Weinhold, Niels;
    • Rosenbluh, Chaggai;
    • Gatt, Moshe E.;
    • Palm, Wilhelm;
    • Azab, Abdel Kareem;
    • Tirosh, Boaz
    Publication type:
    Article
    13
    14
    15
    16

    Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long‐term follow‐up of a multi‐center prospective study

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 1, p. E3, doi. 10.1002/ajh.25651
    By:
    • Ofran, Yishai;
    • Hayun, Michal;
    • Leiba, Ronit;
    • Zuckerman, Tsila;
    • Horowitz, Netanel;
    • Hoffman, Ron;
    • Ringelstein, Shimrit;
    • Lavi, Noa;
    • Frisch, Avraham;
    • Henig, Israel;
    • Gatt, Moshe E.;
    • Hellmann, Ilana;
    • Arad, Ariela;
    • Bulvik, Shlomo;
    • Ram, Ron;
    • Gino‐Moor, Sharon;
    • Saban, Revital;
    • Tvito, Ariella;
    • Rowe, Jacob M.;
    • Ganzel, Chezi
    Publication type:
    Article
    17
    18
    19

    Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 2, p. 130, doi. 10.1002/ajh.23368
    By:
    • Merkel, Drorit;
    • Filanovsky, Kalman;
    • Gafter-Gvili, Anat;
    • Vidal, Liat;
    • Aviv, Ariel;
    • Gatt, Moshe E.;
    • Silbershatz, Itay;
    • Herishanu, Yair;
    • Arad, Ariela;
    • Tadmor, Tamar;
    • Dally, Najib;
    • Nemets, Anatoly;
    • Rouvio, Ory;
    • Ronson, Aharon;
    • Herzog-Tzarfati, Katrin;
    • Akria, Luiza;
    • Braester, Andrei;
    • Hellmann, Ilana;
    • Yeganeh, Shay;
    • Nagler, Arnon
    Publication type:
    Article
    20
    21

    Nivolumab, Pomalidomide, and Elotuzumab Combination Regimens for Treatment of Relapsed and Refractory Multiple Myeloma: Results from the Phase 3 CheckMate 602 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. 703, doi. 10.1016/j.clml.2024.05.014
    By:
    • Oriol, Albert;
    • Hájek, Roman;
    • Spicka, Ivan;
    • Sandhu, Irwindeep;
    • Cohen, Yael C.;
    • Gatt, Moshe E.;
    • Mariz, José;
    • Cavo, Michele;
    • Berdeja, Jesús;
    • Jin, Kexin;
    • Bar, Merav;
    • Das, Prianka;
    • Motte-Mohs, Ross La;
    • Wang, Yu;
    • Perumal, Deepak;
    • Costa, Luciano J.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Neurological misdiagnoses of lymphoma.

    Published in:
    Neurological Sciences, 2021, v. 42, n. 5, p. 1933, doi. 10.1007/s10072-020-04724-8
    By:
    • Makranz, Chen;
    • Arkadir, David;
    • Nachmias, Boaz;
    • Gatt, Moshe E.;
    • Eliahou, Ruth;
    • Atlan, Karine;
    • Mordechai, Anat;
    • Goldshmit, Netta;
    • Lossos, Alexander
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    TRIM13 ( RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 2, p. 210, doi. 10.1111/bjh.12365
    By:
    • Gatt, Moshe E.;
    • Takada, Kohichi;
    • Mani, Mala;
    • Lerner, Mikael;
    • Pick, Marjorie;
    • Hideshima, Teru;
    • Carrasco, Daniel E.;
    • Protopopov, Alexei;
    • Ivanova, Elena;
    • Sangfelt, Olle;
    • Grandér, Dan;
    • Barlogie, Bart;
    • Shaughnessy, John D.;
    • Anderson, Kenneth C.;
    • Carrasco, Daniel R.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48